Intestinal Cell News Volume 8.15 | Apr 29 2022

    0
    31







    2022-04-29 | ICN 8.15


    Intestinal Cell News by STEMCELL Technologies
    Vol. 8.15 – 29 April, 2022
    TOP STORY

    β-Hydroxybutyrate Suppresses Colorectal Cancer

    Scientists identified a metabolite signaling pathway that provided actionable insights toward new strategies for its prevention and therapy.
    [Nature]

    AbstractPress Release
    ON987CXN-may-728x90-2022
    PUBLICATIONSRanked by the impact factor of the journal

    Targeting the miR-34a/LRPPRC/MDR1 Axis Collapse the Chemoresistance in P53 Inactive Colorectal Cancer

    Researchers demonstrated and reported for the first time that leucine-rich pentatricopeptide repeat-containing protein (LRPPRC) was a key functional downstream factor and therapeutic target for P53 mutation-induced chemoresistance.
    [Cell Death & Differentiation]

    Abstract

    CircMAN1A2 Is Upregulated by Helicobacter pylori and Promotes Development of Gastric Cancer

    Investigators found that Helicobacter pylori could induce the upregulation of circMAN1A2 in AGS and BGC823 cells independent of CagA.
    [Cell Death & Disease]

    Full Article

    JAM-A Signals Through the Hippo Pathway to Regulate Intestinal Epithelial Proliferation

    The authors reported that JAM-A interacted with NF2 and LATS1, functioning as an initiator of the Hippo signaling pathway, and observed increased YAP activity in JAM-A-deficient intestinal epithelial cells.
    [iScience]

    AbstractGraphical Abstract

    Hyperglycemia Induces Gastric Carcinoma Proliferation and Migration via the Pin1/BRD4 Pathway

    The role and underlying mechanism of the Pin1/BRD4 axis in hyperglycemia-induced proliferation and migration of gastric cancer cells were analyzed in vivo and in vitro.
    [Cell Death Discovery]

    Full Article

    Long Non-Coding RNA LINC00511 Facilitates Colon Cancer Development through Regulating microRNA-625-5p to Target WEE1

    RNA LINC00511, miR-625-5p, and WEE1 levels were tested in colon cancer tissues and cells. Subcellular localization of LINC00511 was clarified.
    [Cell Death Discovery]

    Full Article

    Reversing Epithelial Polarity in Pluripotent Stem Cell-Derived Intestinal Organoids

    Scientists showed an intestinal organoid model from pluripotent stem cells with reversed polarity where the apical side faced the surrounding culture media and the basal side faced the lumen.
    [Frontiers in Bioengineering and Biotechnology]

    Full Article

    Activin A Promotes Cell Proliferation, Invasion and Migration and Predicts Poor Prognosis in Patients with Colorectal Cancer

    Activin A expression was assessed in colorectal cancer (CRC) tissue specimens from 157 patients with primary CRC and the relationship between activin A levels and clinicopathological characteristics were determined.
    [Oncology Reports]

    Abstract

    Enterotoxigenic Bacteroides fragilis Activates IL-8 Expression through Stat3 in Colorectal Cancer Cells

    Researchers found that co-culture of HT-29 and HCT116 colorectal cell lines with enterotoxigenic Bacteroides fragilis (BF) had a similar effect on activation of IL8 gene and protein expression as treatment with purified BF toxin.
    [Gut Pathogens]

    Full Article
    Tips to prepare for your next conference or networking event
    REVIEWS

    The HER Family as Therapeutic Targets in Colorectal Cancer

    Investigators discuss how HER family members were discovered, their functions and roles in cancer, and most importantly, the developmental history and recent updates of therapies targeting HER family members, with colorectal cancer as a focus.
    [Critical Reviews in Oncology/Hematology]

    AbstractGraphical Abstract

    Role of Ferroptosis in Gastrointestinal Tumors: From Mechanisms to Therapies

    The authors summarize the latest research on ferroptosis, its mechanism of action, and its role in the progression of different gastrointestinal tumors.
    [Cell Biology International]

    Abstract
    INDUSTRY AND POLICY NEWS

    Evoke Pharma Granted FDA Market Exclusivity for GIMOTI®

    Evoke Pharma, Inc. announced that it has been granted new drug product exclusivity by the US FDA for GIMOTI (metoclopramide) nasal spray.
    [Evoke Pharma, Inc.]

    Press Release

    Wireless Device To Provide New Options For Colorectal Cancer Treatment

    A Texas A&M team has begun developing an intracavity device that will allow doctors to eliminate leftover cancer cells during surgery, reducing the need for additional treatments such as chemotherapy.
    [Texas A&M University College of Engineering]

    Press Release
    FEATURED EVENT

    European Association for Cancer Research (EACR) 2022: Innovative Cancer Science

    June 20 – 23, 2022
    Sevilla, Spain

    > See All Events

    JOB OPPORTUNITIES

    PhD Position – Development of Cellulose Particles

    Technical University of Denmark – Lyngby, Denmark

    Research Assistant – Intestinal Epithelium

    University of Glasgow – Glasgow, Scotland, United Kingdom

    Laboratory Research Scientist – Infection and Immunity

    Francis Crick Institute – London, England, United Kingdom

    PhD Position – Intestinal Microbiology

    Technical University of Denmark – Lyngby, Denmark

    Postdoctoral Research Scientist – Intestinal Barrier Health

    University of Oxford – Oxford, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter